RenovoRx Inc at Canaccord Genuity Growth Conference Transcript
Good morning. Thank you for joining us here at the 43rd Annual Canaccord Genuity Growth Conference. My name is Bill Maughan. I'm one of the biotech analysts here. It's my pleasure to introduce Shaun Bagai, CEO of RenovoRx. Shaun?
Great. Thank you, Bill. Appreciate Canaccord for hosting a great conference and hosting me as well and give an opportunity to talk about our story.
So we're focused on a different way to treat cancer. And my name is Shaun Bagai, CEO of RenovoRx. And unfortunately, a lot of us have been touched by cancer through family members, close friends, and we know two things. One is that chemotherapy doesn't work very often. And unfortunately, the current paradigm is, let's give as much poison as possible to hopefully attack the tumor before we attack the patient.
That's not the way it should be done. That's the only way we know so far. We're just trying to flip that on his head. Can we actually make an impact on cancer without destroying the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
